GlassScriptPhysician profile
James Mark Mclellan
NPI 1053658880
$1,785.19
in general payments reported to CMS, 2019-2025
28 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $364 · 2022: $516 · 2023: $423 · 2024: $317 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $356.35 | 2021-2025 | Grafix, Stravix, Renasys Go V2 Home |
| Boston Scientific Corporation | $346.99 | 2021-2025 | Enroute Transcarotid Neuroprotection System |
| Ethicon US, LLC | $121.15 | 2024 | Ethicon, Prolene, Vistaseal |
| Janssen Pharmaceuticals, INC | $117.18 | 2021-2024 | Xarelto |
| Pfizer INC. | $106.33 | 2022-2025 | |
| W. L. Gore & Associates, INC. | $95.33 | 2021-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Paratek Pharmaceuticals, INC. | $63.22 | 2021 | |
| Kerecis Limited | $56.53 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Silk Road Medical, INC. | $48.87 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Kci USA, INC. | $45.36 | 2021 | |
| Shockwave Medical, INC | $44.08 | 2025 | |
| Organogenesis INC. | $36.33 | 2023 | Puraply |
| Lemaitre Vascular, INC. | $34.78 | 2023 | Restoreflow |
| Stryker Corporation | $32.35 | 2025 | Artix Mt |
| Solventum Corporation | $31.44 | 2024 | Activ.A.C. |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $28.73 | 2022 | |
| Becton, Dickinson and Company | $24.85 | 2024 | Venclose Maven Catheter |
| Cardinal Health 200 LLC | $23.59 | 2021 | |
| Medtronic, INC. | $21.96 | 2024 | Hawkone |
| Davol INC. | $21.40 | 2021 | |
| Grifols USA, LLC | $21.22 | 2021 | |
| Neuros Medical, INC. | $20.50 | 2025 | Altius |
| Next Science LLC | $19.73 | 2023 | Blastx, Xperience, Surgx |
| Merit Medical Systems INC | $16.74 | 2024 | Mak Kits |
| Abbott Laboratories | $13.83 | 2021 | |
| Triad Life Sciences INC. | $13.02 | 2022 | |
| Cardiovascular Systems INC. | $11.90 | 2022 | |
| Amgen INC. | $11.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mclellan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.